Annual Shareholders’ Meeting Recap: In his speech at today’s Annual Shareholders’ Meeting, CEO Bernd Montag outlined our strategic focus for the next five years: addressing the rise of noncommunicable diseases such as neurodegenerative and cardiovascular diseases, stroke, and cancer, while supporting health systems worldwide that are under increasing pressure. Montag emphasized how imaging and precision therapy, supported by AI, can create powerful impact. “Healthcare AI has become a key factor in our innovative strength – and the field we are expanding the most,” he said. Supervisory Board Chair Ralf P. Thomas highlighted that becoming a fully independent company will give Siemens Healthineers “greater freedom for strategic development and enhanced transparency, while reducing complexity for the capital market.”
-
-
-
-
-
+1